Billionaire investors are successful for a reason. They do not funnel their money in ordinary places. They spend enormous amounts of resources on the analysis and evaluation of stock and investment options before making a move. That’s why markets pay huge attention to the stocks that are owned by billionaires. In this article we will take a look at some of the healthcare stocks which billionaires were buying in the third quarter. These stocks include Endo International plc – Ordinary Shares (NASDAQ:ENDP), INC Research Holdings Inc (NASDAQ:INCR), Cepheid (NASDAQ:CPHD), Baxter International Inc (NYSE:BAX) and Bristol-Myers Squibb Co (NYSE:BMY).
At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.
Endo International plc – Ordinary Shares (NASDAQ:ENDP)
At the end of the third quarter, 9 billionaires from our database of 64 renowned billionaires were bullish on Endo International plc – Ordinary Shares (NASDAQ:ENDP), having $450.281 million worth of positions in the company, compared to 4 billionaires in the earlier quarter which had $270.56 million worth of shares of the company. The shares of Pennsylvania-based pharmaceutical company have lost over 74% in value since the start of the year. Recently, Susquehanna upgraded Endo International plc (NASDAQ: ENDP) to ‘Positive’ from ‘Neutral’ with a price target of $20. Overall, a total of 32 hedge funds in our database of 742 funds were bullish on Endo International plc (NASDAQ: ENDP) as of the end of the third quarter.
INC Research Holdings Inc (NASDAQ:INCR)
At the end of September, 6 out of 64 famous billionaires in our list were long INC Research Holdings Inc (NASDAQ:INCR) with $99.18 million positions, up from 2 billionaires and $30.59 million stakes in total. The North Carolina-based company reported third quarter EPS of $0.64, above the analysts’ forecast of $0.63, while revenue of $259.56 million slightly missed the projected $259.89 million. For full fiscal 2016, INC Research expects EPS of $2.48-$2.52, versus prior guidance of $2.39-$2.50 and the consensus estimate of $2.48. 30 hedge funds from our database were long INC Research Holdings Inc( NASDAQ:INCR) at the end of September, versus 25 funds a quarter earlier.
On the next page, we will discuss some other healthcare stocks in which billionaires are interested in.